Online inquiry

IVTScrip™ mRNA-Human ASGR1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23310MR)

This product GTTS-WK23310MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASGR1 protein. This product can be used in CD1C+_B dendritic cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001197216.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 432
UniProt ID P07306
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASGR1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23310MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27481MR IVTScrip™ mRNA-Human ARRDC3-AS1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARRDC3-AS1
GTTS-WK25650MR IVTScrip™ mRNA-Human ARL6IP6, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL6IP6
GTTS-WK8641MR IVTScrip™ mRNA-Human ADGRG1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ADGRG1
GTTS-WK17133MR IVTScrip™ mRNA-Human AIM1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA AIM1
GTTS-WK23168MR IVTScrip™ mRNA-Human ARF6, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARF6
GTTS-WK27208MR IVTScrip™ mRNA-Human ASF1A, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ASF1A
GTTS-WK22971MR IVTScrip™ mRNA-Human ARPC5, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARPC5
GTTS-WK24965MR IVTScrip™ mRNA-Human ARF4, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARF4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →